Quick Answer
Decoy Therapeutics Inc. reported Shares Outstanding of 1.44 million shares for fiscal year 2024.
Decoy Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 1.44M | +192.7% |
| 2023 | 492,304 | -78.2% |
| 2022 | 2.26M | +24.7% |
| 2021 | 1.81M | -92.4% |
| 2020 | 23.81M | +427.8% |
| 2019 | 4.51M | +121.9% |
| 2018 | 2.03M | -88.6% |
| 2017 | 17.80M | +6.1% |
| 2016 | 16.77M | +6.6% |
| 2015 | 15.74M | +610.5% |
| 2014 | 2.22M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 944,491 | -34.5% | -55.6% |
| June 30, 2025 | 2.13M | +231.8% | +2.2% |
| March 31, 2025 | 2.08M | -51.7% | +2066.8% |
| December 31, 2024 | 96,077 | -80.5% | -93.3% |
| September 30, 2024 | 1.44M | -63.4% | +124.8% |
| June 30, 2024 | 641,177 | -80.9% | -85.1% |
| March 31, 2024 | 4.31M | +74.8% | +776.4% |
| December 31, 2023 | 492,304 | -78.2% | -87.5% |
- Decoy Therapeutics Inc. showed an increase of +192.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2024 period, Decoy Therapeutics Inc.’s shares outstanding has declined by 35.0% (from 2.22 million shares to 1.44 million shares).
- The most recent figure is from Decoy Therapeutics Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 21, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: